EGFR and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), oestradiol activates the epidermal growth factor receptor (EGFR) pathway and stimulates CXCR4 expression, which promote proliferation, angiogenesis, cell migration, and metastasis [38].